Trial Profile
High-dose daptomycin in patients with VRE bacteraemia
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Jan 2014
Price :
$35
*
At a glance
- Drugs Daptomycin (Primary)
- Indications Bacteraemia; Vancomycin-resistant enterococcal infections
- Focus Therapeutic Use
- 09 Jan 2014 New trial record